INTRODUCTION
On ingestion of micro-organisms, phagocytic cells undergo a rapid burst of oxygen consumption, leading to the production of microbicidal oxidants. The biochemical basis for this respiratory burst is the activation of a superoxide-generating NADPH oxidase. This oxidase is dormant in resting cells and is capable of being activated by several different stimuli [1, 2] . In human neutrophils, the activated enzyme is a multicomponent electrontransport chain composed of a membrane flavocytochrome b558 [3, 4] , containing haem, flavin and NADPH-binding sites [5, 6] and three cytosolic components, p47, p67 and rac 2, a ras-related GTP-binding protein [7] [8] [9] [10] [11] [12] . Several proteins are phosphorylated when the respiratory burst is activated [13] , but the only phosphoproteins that are known to be definitely involved are the 91 kDa and 22 kDa subunits of flavocytochrome b [14] and the 47 kDa cytosolic oxidase protein p47 [15] [16] [17] [18] [19] . By using twodimensional gel electrophoresis [18, 19] , a chain of increasingly phosphorylated p47 was demonstrated in the cytosol and membranes of phorbol 12-myristate 13-acetate (PMA)-activated neutrophils.
The stimulus-receptor-coupled responses of human neutrophils to a variety of agonists result in a complex array of metabolic events ultimately linked to the activation of the NADPH oxidase enzyme. Studies in whole cells show that the oxidase can be activated by a variety of stimuli and suggest that there are several pathways to oxidase activation [20] [21] [22] . A direct role for protein kinase C (PKC) in the activation of NADPH oxidase has been suggested, since PKC translocates from cytosol to cell membranes and mediates phosphorylation of p47 during stimulation with PMA [7, 23, 24] . However, use of PKC and phospholipase A2 (PLA2) inhibitors has clearly demonstrated'. that the mechanism of oxidase activation is more complicated [25] . In both neutrophils and macrophages, an increase in PLA2 OZ was observed. Addition of 10 ,uM free AA, which by itself did not stimulate superoxide generation, restored oxidase activity in neutrophils treated with PLA2 inhibitors. These findings indicate that phosphorylation and translocation of the cytosolic factors to the membranes are not sufficient for generating superoxide; a functional PLA2 is also needed to stimulate the oxidase activity. The inhibition of PLA2 activity did not prevent the phosphorylation of p47, suggesting that the location of PLA2 is downstream of and does not activate protein kinase C.
activity and a release of arachidonic acid (AA) has been reported to occur in association with stimuli which also activate the oxidase [25] [26] [27] [28] . In a recent study, we have demonstrated the release of AA and the involvement of PLA2 in the transduction pathway stimulating the NADPH oxidase activity in peripheral blood monocytes by lipoteichoic acid or opsonized zymosan (OZ) [29] . Furthermore, AA itself stimulates superoxide in intact cells, in a cell-free assay and in electropermeabilized cells [30] [31] [32] . Although much work during the past few years delineated an increasingly complex set of reactions exhibiting evidence of exquisite regulation, the exact mechanisms leading to activation of the oxidase and the relationships between the different transduction pathways are unclear. The present study focuses on the role and the location of PLA2 activity in the transduction pathway(s) leading to activation of the NADPH oxidase complex in human neutrophils.
MATERIALS AND METHODS Neutrophil Isolation
Neutrophils were separated by Ficoll/Hypaque centrifugation, dextran sedimentation, and hypotonic lysis of erythrocytes.
Superoxide-anion measurements
The production of superoxide anion (02-) by intact cells was measured as the superoxide dismutase-inhibitable reduction of acetyl-ferricytochrome c as described [33] I To whom correspondence should be addressed. 217 superoxide generation were determined by using the absorption coefficient c,550 = 21 mM-1 cm-'.
[32P]P, loading Loading with [32P]Pi was performed as described previously [19] . Neutrophils were suspended at 107 cells/ml in loading buffer (137 mM NaCl, 0.8 mM MgCl2, 5.4 mM KC1, 5.6 mM glucose, 1O mM Hepes, pH 7.4) and treated with 5 mM di-isopropyl fluorophosphate for 30 min at room temperature. The cells were washed once, suspended at 108 cells/ml in the same buffer supplemented with 1 mCi/ml [32P]Pi (200 mCi/mmol), and incubated with intermittent mixing for 90 min at 30 'C. The loaded neutrophils were pelleted by centrifugation, and suspended at 5 x 105 cells/ml in the same buffer at 37 'C, supplemented with 1 mM MgCl2 and 0.5 mM CaCl2. The inhibitors were added 3 min before addition of the stimulants for 5 min. The reaction was terminated by a 5-fold dilution with iced loading buffer and the mixture was centrifuged at 500 g for 5 min.
Isolatlon of membrane and cytosol fractions
Membrane and cytosol fractions were prepared as described previously [7] . Cells suspended at 108 cells/ml in relaxation buffer (100 mM KCI, 3 mM NaCl, 3.5 mM MgCl2, 1.25 mM EGTA, 1 mM ATP, 10 mM Pipes, pH 7.4) containing 1 mM phenylmethanesulphonyl fluoride and 100 1tM leupeptin at 4 'C were sonicated for 3 x 10 s, resulting in about 95 % cell breakage. Nuclei, granules and unbroken cells were removed by centrifugation (2 min, 15 600 g) and the post-nuclear supernatant was made 5 mM in EDTA, 1 mM in Na3V04 and 5 mM in NaF from 20-100-fold-concentrated stock solutions of the phosphatase inhibitors. The supernate was centrifuged in a Beckman airfuge (30 min, 134000 g) to obtain a cell membrane pellet and a cytosol supernatant. Membranes were suspended at 109 cell equivalents/ml in 0.34 M sucrose/half-strength relaxation buffer containing 1 mM dithiothreitol. Solubilized membrane and cytosol were stored at -70°C.
Immunoprecipitatlon, electrophoresis and autoradlography These were performed as described previously [19] . Membranes or cytosol were added to 100 ,u of solubilization buffer (150 mM NaCl, 5 mM EDTA, 10 mM Tris, pH 7.5, 1 % sodium deoxycholate, 1 % Nonidet P-40). Then 2 ,u1 of rabbit antiserum raised against recombinant p47 was added and the mixture was incubated on ice overnight. The extract was adjusted to a volume of 0.4 ml in solubilization buffer containing 30 ,ul of 50 % (w/v) slurry of recombinant Protein G-Sepharose. The mixtures of the extracts and the Protein G-Sepharose were tumbled end-overend for 1 h, and washed with 2 x 1 ml of solubilization buffer containing 20% (w/v) sucrose and 0.15 (w/v) BSA, and then with 2 x 1 ml of solubilization buffer containing 20 % sucroseThe samples were boiled in SDS sample buffer, and electrophoresed on an SDS/10 %-polyacrylamide gel. Gels were stained with Coomassie Blue, dried and used for autoradiography with intensifying screens at -70°C. Dried gels were also counted for radioactivity to access the relative 32P content of resolved bands with a Betascope blot analyser (Betagen Corp., Waltham, MA, U.S.A.).
Immunoblot analysis
Immunoblot detection of cytosolic NADPH oxidase components was performed as described [33] . Samples were solubilized in 2 x sample buffer (12% SDS, 8 M urea, 250 mM Tris, 8 mM EDTA, 0.2 mM leupeptin, 2 mM phenylmethanesulphonyl fluoride, pH 6.9). The amount of protein in each sample was quantified by the Pierce BCA protein assay (Pierce Chemical Co., Rockford, IL, U.S.A.) with BSA standards. Cytosols or membranes were analysed by PAGE. The resolved proteins were electrophoretically transferred to nitrocellulose, which was stained with Fast Green to detect protein banding, and then blocked in 5 % (w/v) non-fat dry milk in Tris-buffered saline (TBS; pH 7.4). The blots were incubated in TBS/1 % gelatin containing goat antiserum to either p47 or p67 (a gift from Dr. T. L. Leto). Immunoblots were incubated with 1 ,ug/ml peroxidase-conjugated rabbit anti-goat serum (Biomakor, Rehovot, Israel) and developed with 4-chloro-1-naphthol and H202.
The relative changes of each oxidase component were quantified by using a densitometer (Hoefer Scientific Instruments, San Francisco, CA, U.S.A.). These measurements are adequate to determine the changes in each individual oxidase component under different conditions, but not for comparison between the various components.
Measurement of [3fHAA release
Incorporation and release of [3H]AA were performed as previously reported [29] . Neutrophils (108/ml) were incubated for 30 min at 37°C in Ca2+/Mg2+-free PBS containing 1 ,tCi of [3H]AA (100 mCi/mmol). Neutrophils were washed once with PBS containing 0.1 % fatty-acid-free human serum albumin (HSA) and twice with PBS. The pellet was resuspended to 107 cells/ml in incubation buffer (137 mM NaCl, 5.4 mM KCI, 5-6 mM glucose, 10 mM Hepes, pH 7.4) with 0.9 mM CaCl2 and 0.5 mM MgCl2, containing 0.1 % HSA. The incorporation of [3H]AA was 81 + 7.6% of the total radioactivity added to the cells after incubation for 30 min. Neutrophils (107/ml) were incubated in 37°C with the appropriate stimulus in the presence or absence of inhibitors for 2.5, 5, 10 and 15 min. The reaction was terminated by centrifugation at 4°C, and samples of the supernatants were counted for radioactivity by liquidscintillation (Packard 1900CA spectrometry).
Statistical analysis
The differences between means were analysed by Student's t test. The plots were drawna as -least-squares regression lines and tested by analysis of variance.
RESULTS
The effect of PLA2 inhibitors on superoxide generation in neutrophils is shown in Figure 1 . 4-Bromophenacyr bromide (BPB) or quinacrine inhibited superoxide generation in neutrophils activated by either 50 ng/ml PMA or 1 mg/ml OZ in a dose-dependent manner. The effect of BPB on PLA2 activity was studied simultaneously with its effect on superoxide generation. As presented in Figure 2 , BPB inhibited [3H]AA release in neutrophils activated by 50 ng/ml PMA or 1 mg/ml OZ. The inhibition of PLA2 activity by BPB was parallel to the inhibition of superoxide generation shown in Figure 1 . Quinacrine showed similar results (results not shown).
The inhibition of superoxide generation in the presence of PLA2 inhibitors could be restored by addition of free AA. As shown in Figure 3 , the inhibition of superoxide production by quinacrine in PMA-stimulated neutrophils could be reversed by addition of AA at a concentration of 10 ,uM, which by itself caused-a limied' proluction, of superoxide. Additionof -stearic, Five other experiments showed similar results, and in all the experiments there were no differences in the amount of phosphorylation in p47 between the BPB-treated and untreated neutrophils. (20 ,uM) did not cause any inhibition of the phosphorylation of p47. We used the PKC inhibitor staurosporine as a control which did inhibit the phosphorylation of p47. As shown in Figure 5 , similar results were obtained by 10 lM BPB, which causes total inhibition of the oxidase activity, but did not affect the phosphorylation of p47 in the cytosol or the membranes. We then studied the effect of BPB on the translocation of the cytosolic factors p47 and p67 to neutrophil membranes by immunoblot analysis. We used 5 ,M or 10 lM BPB, which respectively caused partial or total inhibition of superoxide production. As presented in the representative immunoblot ( Figure 6 ) and the means + S.E.M. of the densitometry from four experiments (Table 2) , BPB did not inhibit the translocation of either p47 or p67 to membranes of neutrophils stimulated by PMA or OZ.
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To explore further the involvement of AA in the oxidase activity, we examined simultaneously the time-and dose- As shown in Figure 7 , the kinetics of [3H]AA release occurred on a similar time-scale to the production of superoxide. In stimulusdose-response studies, there is a high correlation between superoxide production and [3H]AA release stimulated by PMA in the range 50-500 nM (Figure 8a) or by OZ in the range 0.001-1 mg/ml (Figure 8b ). Since PKC is the major kinase responsible for the phosphorylation of the oxidase cytosolic factor p47 [18, 19] , we studied the effect of the PKC inhibitor staurosporine on PLA2 activity. As shown in Figure 9 
DISCUSSION
The present study shows that with either PMA or OZ as the stimulus, both activation of the oxidase and the release of [3H]AA were inhibited simultaneously by PLA2 inhibitors, in a dose-dependent manner (Figures 1 and 2 ). The presence of PLA2 inhibitors in OZ-or PMA-stimulated neutrophils did not affect the phosphorylation of p47 or the translocation of p47 and p67 to the membranes. In spite of maximal phosphorylation and translocation of these two cytosolic factors to the membranes, there was no oxidase activity in the presence of PLA2 inhibitors; only when free AA was added the activity was regained. The effect of AA in restoring the oxidase activity was also shown [25] in PMA-stimulated neutrophil-derived cytoplasts in the presence of various PLA2 inhibitors. These observations indicate that AA has a putative role in the activation of the oxidase and that phosphorylation and translocation, although necessary, are not sufficient for oxidase activity. In accordance with our findings, Lu et al. [34] reported that increased phosphorylation of p47 is not sufficient for superoxide production in cells treated with okadaic acid. The dose-dependent and time-dependent patterns of superoxide production occurred on a similar time scale to the release of [3H]AA (Figures 7 and 8) induced by OZ or PMA, suggesting that PLA2 activity is required for both induction of NADPH oxidase activity and its maintenance over time.
In our recent study [35] we have suggested that AA may act as a positive modulator for the NADPH oxidase. This suggestion is based on the results demonstrating that very low concentrations of AA (10,M) affect the assembled form of the oxidase in isolated cytosplasmic membranes and endosomes, by decreasing the Km and increasing the Vm.. The effect of AA on the kinetic parameters of the enzyme is most readily explained by interaction of AA with the assembled oxidase or by affecting its close environment.
On the other hand, although PLA2 is needed for oxidase activation, its activity alone is insufficient to activate the oxidase, since oxidase activity is inhibited in the presence of the PKC inhibitor staurosporine. It has been suggested [36] that NADPH oxidase may be activated by a PLA2-mediated process without involvement of p47 phosphorylation. In addition, it has been shown recently [37] that the translocation of the cytosolic factors is independent of PKC activity and is linked to transmembrane signalling involving Ca2+ transients and production of lipidic second messengers. In contrast, we have recently shown [38] that in OZ-stimulated neutrophils in the presence of staurosporine there is a residual phosphorylation of p47 (also shown in Figure  4 and Table 1 in the present study), which is probably responsible for the oxidase activity obtained in these conditions. At a higher concentration of staurosporine both phosphorylation of p47 and superoxide generation induced by OZ were inhibited. Thus PLA2 The location of PLA2 activity in the signal-transduction pathway leading to oxidase activation has not as yet been defined. PLA2 activity may be involved in the activation of the oxidase at multiple sites: directly on PKC, downstream of PKC and mediated by PKC activity or at a site independent of PKC activity. We show here that phosphorylated p47 was found in cytosol and membranes of neutrophils induced by either PMA or OZ in the presence of PLA2 inhibitors (Figures 4 and 5 [40] [41] [42] , a major obstacle to assignment of its physiological role in this process is the very high concentration needed for enzyme activation (100-600,M AA) [43, 44] . It has been reported that these high concentrations of AA activate the a-isoform of PKC [43, 44] . The y-type enzyme, which is activated by very low, possibly physiological, concentrations of AA (10,tM) , is found only in the central nervous system [45] . The predominant isoform present in human neutrophils, PKC-, [46] , is activated by PMA or increased intracellular [Ca2"] [47] , is sensitive to conventional PKC inhibitors [48] ), phosphorylates p47, and is involved in activation of the oxidase [18, 19] . However, this PKC isoform responds very poorly to AA and other fatty acids [47, 49] . Thus these findings are in agreement with our results demonstrating that, in events leading to oxidase activation, AA does not mediate PKC activity.
In accordance with work by others [35, 50, 51] , our study demonstrates that [3H]AA release stimulated by PMA or OZ is not affected by staurosporine in a range specific for PKC inhibition [52] which does inhibit PMA-stimulated oxidase activity (Figure 8 ). These results suggest that PKC does not mediate the activation of PLA2 in the events leading to stimulation of the oxidase in human neutrophils. In contrast, several studies suggest that PKC activation mediates the release of [3H]AA by PLA2 in various cell types [53] [54] [55] , since downregulation of PKC by various PKC inhibitors or prolonged incubation with PMA prevented [3H]AA release. The discrepancy between the results may be due to differences in the cell types and conditions studied.
The nature of PLA2 activated in neutrophils during stimulation of the oxidase is not yet clear. Since PLA2 activity is not affected by the PKC inhibitor staurosporine in a range specific for PKC inhibition (Figure 9 ), we may suggest that in these conditions the cell-associated type 14 kDa PLA2, found in neutrophils [56] , shown to be activated by PMA [57] and which does not undergo phosphorylation [58] , is responsible for the release of [3H]AA during the stimulation of the oxidase. However, the cytosolic 85 kDa PLA2 (cPLA2) [59, 60] , which accounts for approx. 50 % of the total PLA2 in rabbit neutrophils [61] , may also participate. cPLA2 undergoes phosphorylation on serine residues [62] mediated by MAP (mitogen-activated protein) kinase [63] . The phosphorylation and activation of cPLA2 is inhibited by I ,M stauroporine [62] , in accordance with the inhibition of [3H]AA release by the same concentration of staurosporine obtained in our study.
In conclusion, the results presented in this study show that oxidase activity was inhibited in the presence of PLA2 inhibitors, in spite of the p47 phosphorylation and the translocation of p47 and p67 to the membranes, suggesting a putative role for PLA2 activity in the activation of NADPH oxidase. The types and mechanisms of activation of PLA2 are unclear, and it is not clear whether the stimulation of PLA2 activity by OZ or PMA is through the same mechanisms or through different ones.
